Lataa...
Invasive fungal infections in acute myeloid leukemia treated with venetoclax and hypomethylating agents
The combination of venetoclax with hypomethylating agents (VEN-HMAs) showed promising activity in newly diagnosed and relapsed/refractory (r/r) acute myeloid leukemia (AML). Treatment with VEN-HMAs results in prolonged cytopenia, thereby exposing patients to invasive fungal infections (IFIs). Here,...
Tallennettuna:
| Julkaisussa: | Blood Adv |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Society of Hematology
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6963254/ https://ncbi.nlm.nih.gov/pubmed/31816059 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019000930 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|